Mylan (MYL) Gains Early After Taking Action on EpiPen Pricing

August 25, 2016 7:51 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

After dropping sharply over the past few sessions on headline risk related to EpiPen pricing, Mylan (NASDAQ: MYL) shares are gaining 3% early after the company announced plans to reduce patient cost through savings card which will cover up to $300 for their EpiPen 2-Pak.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Add Your Comment